New treatment fails to save patients with cardiogenic shock after heart attackBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7599.872-b (Published 26 April 2007) Cite this as: BMJ 2007;334:872
Cardiogenic shock after myocardial infarction is often lethal. The urgent search for better treatments led scientists to the nitric oxide pathway, which is activated during a heart attack and causes vasodilation and myocardial depression. Preventing the release of nitric oxide …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial